These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12403493)

  • 1. Thrombotic events in compound heterozygotes for a high affinity hemoglobin variant: Hb Milledgeville [alpha44(CE2)Pro-->Leu (alpha2)] and factor V Leiden.
    Hanss M; Lacan P; Aubry M; Lienhard A; Francina A
    Hemoglobin; 2002 Aug; 26(3):285-90. PubMed ID: 12403493
    [No Abstract]   [Full Text] [Related]  

  • 2. Three new variants of the alpha1-globin gene without clinical or hematologic effects: Hb Hagerstown [alpha44(CE2)Pro-->Ala (alpha1)]; Hb Buffalo [alpha89(FG1)His-->Gln (alpha1)], a hemoglobin variant from Somalia and Yemen; Hb Wichita [alpha95(G2)Pro-->Gln (alpha1)]; and a second, unrelated, case of Hb Roubaix [alpha55(E4)Val-->Leu (alpha1)].
    Hoyer JD; McCormick DJ; Snow K; Lawler J; Jadick M; Grageda R; Early JL; Ball C; Skarda P; Kubik KS; Holmes MW; Fairbanks VF
    Hemoglobin; 2002 Aug; 26(3):291-8. PubMed ID: 12403494
    [No Abstract]   [Full Text] [Related]  

  • 3. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
    Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four new beta chain hemoglobin variants without clinical or hematological effects: Hb San Bruno [beta39(C5)Gln-->His]; Hb Fort Dodge [beta93(F9)Cys-Tyr]; Hb Rhode Island [beta116(G18)His-->Tyr]; and Hb Inglewood [beta142(H20)Ala-->Thr].
    Hoyer JD; McCormick DJ; Snow K; Kubik KS; Holmes MW; Dawson DB; Shaber R; Marner M; Hosmer J; Shinno N; Fairbanks VF
    Hemoglobin; 2002 Aug; 26(3):299-303. PubMed ID: 12403495
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor XIIIV34L is not an additional genetic risk for venous thrombosis in factor V Leiden carriers.
    Morange PE; Henry M; Brunet D; Aillaud MF; Juhan-Vague I
    Blood; 2001 Mar; 97(6):1894-5. PubMed ID: 11263439
    [No Abstract]   [Full Text] [Related]  

  • 6. Hb Yaoundé [beta134(H12)Val-->Ala], a new neutral variant found in association with Hb Kenitra.
    Yapo AP; Promé D; Claparols C; Riou J; Galactéros F; Wajcman H
    Hemoglobin; 2001 Feb; 25(1):97-101. PubMed ID: 11300355
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new hemoglobin variant: Hb Badalona (beta31[B13]Leu-->Val).
    Junca J; Villegas A; Ropero P; González FA; Motos A; Valverde F
    Ann Hematol; 2002 Apr; 81(4):179-81. PubMed ID: 11976817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.
    Adamczuk Y; Iglesias Varela ML; Forastiero R; Martinuzzo M; Cerrato G; Pombo G; Carreras LO
    Thromb Haemost; 2000 Mar; 83(3):509-10. PubMed ID: 10744162
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
    Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):713-20. PubMed ID: 11734673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex interaction of hemoglobin (Hb) Nakhon Ratchasima [α63(E12)Ala→Val], a novel α2-globin chain variant with Hb E [β26(B8)Glu→Lys] and a deletional α(+)-thalassemia.
    Srivorakun H; Fucharoen G; Puangplruk R; Kheawon N; Fucharoen S
    Eur J Haematol; 2011 Jul; 87(1):68-72. PubMed ID: 21447006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hb Phimai [β72(E16)Ser→Thr]: a novel β-globin structural variant found in association with Hb constant spring in pregnancy.
    Singsanan S; Srivorakun H; Fucharoen G; Puangplruk R; Fucharoen S
    Hemoglobin; 2011; 35(2):103-10. PubMed ID: 21417566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new examples of Hb St. Etienne [beta 92(F8)HisGln] in association with venous thrombosis.
    Au NH; Wong AY; Vickars L; MacGillivray RT; Wadsworth LD
    Hemoglobin; 2009; 33(2):95-100. PubMed ID: 19373584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of mild and severely unstable alpha chain variants: the first observation of a compound heterozygote with Hb Setif [alpha94(G1)Asp-->Tyr (alpha2)] and Hb Agrinio [alpha29(B10)Leu-->Pro (alpha2)] in a Greek family.
    Douna V; Papassotiriou I; Stamoulakatou A; Metaxotou-Mavrommati A; Kanavakis E; Traeger-Synodinos J
    Hemoglobin; 2008; 32(6):592-5. PubMed ID: 19065338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden: a risk factor for renal vein thrombosis in renal transplantation.
    Wheeler MA; Taylor CM; Williams M; Moghal N
    Pediatr Nephrol; 2000 Jun; 14(6):525-6. PubMed ID: 10872199
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinicobiological study of 100 symptomatic patients with factor V Leiden mutation].
    Vatan R; Delpeu K; Vergnes C; Constans J; Le Bougeant P; Nurden P; Roudaut MF; Boisseau M; Le Métayer P; Morlat P; Longy-Boursier M; Le Bras M; Beylot J; Midy D; Baste JC; Conri C
    Rev Med Interne; 2000 May; 21(5):465-6. PubMed ID: 10874771
    [No Abstract]   [Full Text] [Related]  

  • 19. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hb aubagne [beta64(E8)Gly-Ala]: a new unstable beta chain variant found in a French family.
    Lacan P; Badens C; Lena-Russo D; Merono F; Thuret I; Aubry M; Couprie N; Francina A
    Hemoglobin; 2002 May; 26(2):163-7. PubMed ID: 12144059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.